ADVENTRX Pharmaceuticals (ANX) Stock Quote

Detailed Quote for ADVENTRX Pharmaceuticals (ANX) 
$ 0.715   -0.0056 (-0.78%) Volume: 602.36 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 0.72   0.005 (+0.70%) Volume: 4.1 k 7:58 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
0.715
Change $
0.0056
Change %
0.78%
Tick
N/A
Bid
0.66
Bid Size
300
Ask
N/A
Ask Size
0
Open
0.73
High
0.73
Low
0.675
Prev Close
0.7206
Last Trade
2/10/12
Volume
602.36 k
52 Wk Hi
4.21
52 Wk Low
0.56
Market Cap
18.92 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
26,465,709
EPS (TTM)
-0.56
PE Ratio
N/A
Exchange
AMX
News and Media for ADVENTRX Pharmaceuticals  (ANX) 
Sector News | Topic News
News for ANX
Tue, Feb 07, 2012
8:00 AM ADVENTRX Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 14 - PR Newswire
Thu, Feb 02, 2012
9:15 AM Vista Partners Publishes February 2012 Newsletter - PR Newswire
Tue, Jan 31, 2012
8:20 AM Biotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking Strong - Marketwire
Thu, Dec 15, 2011
9:15 AM Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire
Thu, Dec 01, 2011
8:30 AM ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 - PR Newswire
Wed, Nov 16, 2011
3:41 PM ADVENTRX Announces Closing of Public Offering - PR Newswire
Tue, Nov 15, 2011
8:16 AM Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground - Marketwire
Fri, Nov 11, 2011
8:00 AM ADVENTRX Prices Public Offering of Stock - PR Newswire
Thu, Nov 10, 2011
4:28 PM ADVENTRX Announces Public Offering of Stock - PR Newswire
Mon, Nov 07, 2011
8:00 AM ADVENTRX Reports Third Quarter 2011 Financial Results - PR Newswire
Wed, Oct 26, 2011
8:16 AM Drug Approval Rate Stagnant -- Nektar and ADVENTRX Look to Defy Odds - Marketwire
8:00 AM ADVENTRX and FDA Reach Agreement on Pivotal Study for ANX-514 - PR Newswire
Wed, Oct 19, 2011
8:00 AM ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26 - PR Newswire
Tue, Oct 04, 2011
8:16 AM ADVENTRX Pharmaceuticals and Cell Therapeutics Look Promising as Fourth Quarter Kicks Off - Marketwire
Fri, Sep 30, 2011
4:30 PM ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA - PR Newswire
Tue, Sep 13, 2011
8:16 AM Dendreon and ADVENTRX Spread Awareness in Hopes of Boosting Revenues - Marketwire
Fri, Sep 09, 2011
9:15 AM Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $7.50 Target Price - PR Newswire
Tue, Sep 06, 2011
8:00 AM ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12 - PR Newswire
Tue, Aug 30, 2011
8:00 AM ADVENTRX Provides Update on All Three Pipeline Products - PR Newswire
Fri, Aug 12, 2011
8:16 AM Big Pharma to Shift Focus to Biotech Firms Such as AEterna Zentaris and ADVENTRX - Marketwire
More News for ANX >>

Tags for ADVENTRX Pharmaceuticals

Research stocks or mutual funds related to ADVENTRX Pharmaceuticals by keywords or tags. Find companies that have a similar focus to ANX. The keywords below have been associated to ANX by either user submission or electronic means.

biotechnology company clinical trial logistics pharmaceuticals research mining dust control gold mining methods mining safety canadian mining pharmaceutical market pharmaceuticals clinical trials pharmaceuticals companies generic pharmaceutical copper mining company pharmaceuticals logistics mining machinery pharmaceutical investment gold mines mining trommel gold stock coal mining stickers canadian gold mining mining engineer dupont pharmaceuticals pharma marketing used mining equipment surface mining equipment gold and mining pharma manufacturing mining claims underground mining mining business pharma license mining consultants novartis pharmaceuticals kv pharmaceutical company uranium mining company history of coal mining generic products junior mining stocks pharmaceutical cro pharma companies placer mining iron mining pharma consulting pharmaceutical sales san diego biotech companies company patent gold mining california biotech pharmaceutical company biotech corporation pharmaceutical development